Drug-induced cataract

DRUGADVERS_CATAR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H26.3# 1 out of 7 registries used, show all original rules.	869
4. Check minimum number of events None	869
5. Include endpoints None	869
6. Filter based on genotype QC (FinnGen only)	846

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	DRUGADVERS_CATAR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H263
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Drug-induced cataract based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	4232	2397	1803
Only index persons	3685	2140	1545
Unadjusted period prevalence (%)
Whole population	0.06	0.07	0.05
Only index persons	0.07	0.08	0.06
Median age at first event (years)
Whole population	56.28	56.55	55.83
Only index persons	55.90	56.26	55.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	846	506	340
Unadjusted period prevalence (%)	0.17	0.18	0.16
Median age at first event (years)	55.17	54.46	56.21

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
869: Matched controls
8690

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L04AA06

ATC

mycophenolic acid; systemic

42.6

323.3

201

Z96.1

ICD-10 Finland

Presence of intraocular lens

12.7

316.1

435

635

L04AX01

ATC

azathioprine; systemic

24.2

307.7

258

149

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

20.8

307.7

712

1553

H26.3

ICD-10 Finland

Drug-induced cataract

+∞

307.7

868

127

Kela drug reimbursment

Transplant complication

52.5

307.7

193

L04AA01

ATC

[U] ciclosporin

61.1

283.4

160

H02AB04

ATC

methylprednisolone; systemic

9.7

246.6

414

745

L04AD01

ATC

ciclosporin; systemic

35.2

244.4

159

Z94.0

ICD-10 Finland

Kidney transplant status

55.9

232.2

133

H20.1

ICD-10 Finland

Chronic iridocyclitis

51.0

210.8

123

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

8.4

187.4

315

550

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

25.8

183.2

132

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

13.1

170.5

179

169

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

24.8

169.9

124

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.5

168.6

234

324

L04AD02

ATC

tacrolimus; systemic

39.2

167.4

104

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

49.5

158.9

L01BA01

ATC

methotrexate; systemic

14.0

151.7

150

128

H26.2

ICD-10 Finland

Complicated cataract

33.3

150.5

H26.4

ICD-10 Finland

After-cataract

7.8

140.9

234

394

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.7

140.1

553

2048

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

46.8

130.1

A12AA04

ATC

calcium carbonate; oral

24.1

130.0

A11CC03

ATC

alfacalcidol; systemic

18.3

129.8

108

137

Kela drug reimbursment

Uraemia requiring dialysis

40.7

127.3

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

5.1

125.0

513

1915

TK800

NOMESCO Finland

Hemodialysis

18.8

124.7

102

L04AX03

ATC

methotrexate; systemic

6.3

117.5

240

493

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

58.5

115.2

C03CA01

ATC

furosemide; systemic

4.8

113.3

426

1461

M05BA04

ATC

alendronic acid; oral

6.9

111.8

203

370

H26.02

ICD-10 Finland

Presenil cataract

12.4

111.8

117

108

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

27.7

110.2

CJB10

NOMESCO Finland

Laser discission of secondary cataract

7.3

109.7

185

312

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.0

106.6

630

2993

Z49.1

ICD-10 Finland

Extracorporeal dialysis

23.7

106.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

7.9

105.5

161

243

H02AB06

ATC

prednisolone; systemic

4.9

102.0

635

3098

N18.0

ICD-10 Finland

End-stage renal disease

35.0

102.0

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

7.0

99.4

173

300

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

7.2

98.8

165

274

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.1

98.6

263

677

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

32.3

96.4

H02AB09

ATC

hydrocortisone; systemic

13.8

96.4

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.2

96.1

159

261

V03AE01

ATC

polystyrene sulfonate; oral

26.4

94.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

8.2

94.1

136

192

B05DA

ATC

Isotonic solutions

35.1

92.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

28.4

89.6

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

27.3

88.3

B03XA01

ATC

erythropoietin; parenteral

31.0

87.7

B03XA02

ATC

darbepoetin alfa; parenteral

13.4

85.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

5.0

83.9

218

543

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

10.0

76.5

100

P01BA02

ATC

hydroxychloroquine; oral

5.3

76.3

180

411

B05DB

ATC

Hypertonic solutions

35.4

74.1

Z49.2

ICD-10 Finland

Other dialysis

31.7

73.2

S01BA04

ATC

prednisolone; ophthalmic

11.8

72.1

N18.8

ICD-10 Finland

Other chronic renal failure

13.0

71.9

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.2

68.9

130

241

Z49.0

ICD-10 Finland

Preparatory care for dialysis

22.5

68.7

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

16.7

68.0

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.6

67.2

188

491

H02AB07

ATC

prednisone; oral

4.1

66.3

227

690

J01MA12

ATC

levofloxacin; systemic

3.7

66.2

276

961

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

5.3

65.2

149

329

S01BC05

ATC

ketorolac; ophthalmic

8.5

64.8

114

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.5

63.9

185

495

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.4

62.5

112

197

R50.9

ICD-10 Finland

Fever, unspecified

3.8

62.2

237

773

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.5

60.0

134

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

60.0

318

1279

S01BA01

ATC

dexamethasone; ophthalmic

7.5

59.5

132

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.5

57.8

266

977

S01EC01

ATC

acetazolamide; systemic

10.7

57.3

S01ED51

ATC

timolol, combinations; ophthalmic

5.0

56.6

136

312

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.0

56.4

109

A07EC01

ATC

sulfasalazine; oral, rectal

4.6

56.0

150

376

A07AA02

ATC

nystatin; oral

5.4

54.8

117

242

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

7.7

54.6

113

L04AB04

ATC

adalimumab; parenteral

9.6

54.3

S01ED01

ATC

timolol; ophthalmic

8.1

52.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.9

52.7

496

2708

ZX120

NOMESCO Finland

Intravenous

4.1

52.5

165

466

L88

ICPC

Rheumatoid/seropositive arthritis

6.3

51.8

163

TPH04

NOMESCO Finland

Cathetrisation of vein

3.1

51.4

295

1226

J01FF01

ATC

clindamycin; systemic

3.0

51.3

351

1610

H25.8

ICD-10 Finland

Other senile cataract

4.3

51.0

152

412

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

8.0

50.7

L04AA13

ATC

[U] leflunomide

8.1

50.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.4

49.6

228

828

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.3

49.5

107

223

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

19.4

49.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.8

46.9

363

1761

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

7.2

46.9

107

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

6.9

46.7

117

S01EA05

ATC

brimonidine; ophthalmic

9.1

46.1

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.9

44.6

113

M01CB01

ATC

sodium aurothiomalate; parenteral

14.3

44.5

XCK10

NOMESCO Finland

Photography of fundus of eye

3.9

44.3

150

444

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.1

43.6

230

900

B07.9

ICD-10 Finland

Verruca simplex

6.3

42.9

131

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.8

42.6

145

430

J01MA02

ATC

ciprofloxacin; systemic

2.6

42.2

426

2331

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.8

42.2

147

443

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

5.1

41.1

197

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.5

41.0

167

557

A41.9

ICD-10 Finland

Sepsis, unspecified

6.5

40.6

114

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

5.1

39.2

185

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

38.6

140

432

S01BA07

ATC

fluorometholone; ophthalmic

10.2

38.6

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.4

38.4

162

551

M04AA01

ATC

allopurinol; systemic

3.3

38.3

165

569

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

10.7

38.0

ZXA05

NOMESCO Finland

Left side

2.7

38.0

293

1391

NF1AA

NOMESCO Finland

Hip X-ray examination

3.8

37.8

129

382

ZXA00

NOMESCO Finland

Right side

2.6

37.7

316

1562

Z2446

NOMESCO Finland

Social worker

3.9

37.6

120

339

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

15.6

37.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

37.1

205

817

R03AC12

ATC

salmeterol; inhalant

5.0

36.7

179

ZXD05

NOMESCO Finland

Urgent procedure

2.5

36.4

338

1748

R03DA04

ATC

theophylline; systemic, rectal

5.1

36.0

170

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.8

35.8

191

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.0

35.4

116

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.8

35.1

120

355

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.3

34.7

148

505

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.6

34.7

129

GD1AD

NOMESCO Finland

Thorax CT examination

4.2

34.5

258

S01BC03

ATC

diclofenac; ophthalmic

7.4

33.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.9

33.8

114

J01MA14

ATC

moxifloxacin; systemic

3.5

33.4

131

424

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.7

33.2

XCK00

NOMESCO Finland

Perimetry

4.3

32.9

235

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

12.2

32.7

M05BA07

ATC

risedronic acid; oral

6.1

32.6

100

WX002

NOMESCO Finland

Sedation and analgesia

2.6

32.6

234

1061

A46

ICD-10 Finland

Erysipelas

3.0

32.6

175

682

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

5.3

32.5

137

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

32.4

233

1057

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

4.9

32.1

166

N02AX02

ATC

tramadol; systemic, rectal

2.3

32.0

457

2816

XG410

NOMESCO Finland

Flow-volume spirometry

4.8

31.9

167

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.3

31.8

136

464

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

31.6

152

556

V03AE02

ATC

sevelamer; oral

40.8

31.4

ZXA10

NOMESCO Finland

Bilateral

2.7

31.1

214

948

A05AA02

ATC

ursodeoxycholic acid; oral

8.7

31.1

TGC00

NOMESCO Finland

Bronchial lavation

6.1

30.9

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.9

30.9

102

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.9

30.9

102

A02BC02

ATC

pantoprazole; systemic

2.6

30.8

662

4829

H25.1

ICD-10 Finland

Senile nuclear cataract

2.5

30.7

268

1329

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.6

30.5

109

331

C08CA05

ATC

nifedipine; systemic

4.2

30.2

218

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.2

30.1

131

451

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.3

29.9

129

442

196

Kela drug reimbursment

Paricalcitol and cinacalcet

36.0

29.9

UJF32

NOMESCO Finland

Coloscopy

2.4

29.1

287

1498

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.6

28.7

209

948

E0000UV, ,

ATC

2.2

28.5

427

2643

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.6

28.5

C08CA02

ATC

felodipine; oral

3.3

28.5

119

399

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

10.3

28.4

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

6.4

28.3

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.5

28.2

171

S97

ICPC

Chronic ulcer skin

3.8

28.1

258

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

6.2

28.0

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.0

28.0

WX140

NOMESCO Finland

Parabulbar anesthesy

4.3

28.0

194

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

8.4

27.9

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

290.4

27.9

UKC02

NOMESCO Finland

Cystoscopy

2.7

27.8

171

712

H04.10

ICD-10 Finland

Dry eye syndrome

2.9

27.8

148

571

WW500

NOMESCO Finland

Blood transfusion

4.7

27.5

149

CS494

NOMESCO Finland

Other visual field testing

6.0

27.5

A07AA09

ATC

vancomycin; oral

10.3

27.5

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.1

27.4

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.4

27.4

110

360

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

26.9

154

617

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

26.8

284

1520

A12AA12

ATC

[U] calcium acetate

144.5

26.8

WW200

NOMESCO Finland

Immunization

5.7

26.8

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

26.7

220

1054

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.1

26.7

201

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

10.3

26.6

M05BX04

ATC

denosumab; parenteral

3.8

26.5

244

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.1

26.2

434

2767

L01AA01

ATC

cyclophosphamide; systemic

32.1

26.1

H30.2

ICD-10 Finland

Posterior cyclitis

41.5

26.0

U14

ICPC

Kidney symptom/complaint

8.4

25.8

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

8.4

25.8

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

6.0

25.6

R03AC13

ATC

formoterol; inhalant

4.0

25.4

208

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

23.4

25.4

C07AB02

ATC

metoprolol; systemic

2.5

25.3

203

959

205

Kela drug reimbursment

Chronic hypertension

2.3

25.3

260

1369

J46

ICD-10 Finland

Status asthmaticus

5.5

25.1

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.0

25.1

123

452

Z94.4

ICD-10 Finland

Liver transplant status

40.1

25.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.1

25.0

117

419

ZZA00

NOMESCO Finland

Split skin graft

5.2

24.9

108

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

5.7

24.8

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

6.3

24.7

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.5

24.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.1

24.7

109

S01FA04

ATC

cyclopentolate; ophthalmic

8.9

24.6

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

28.5

24.6

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

25.2

24.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.1

24.4

182

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

26.3

24.1

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.7

24.0

231

C02CA01

ATC

prazosin; oral

9.3

24.0

TK810

NOMESCO Finland

Hemofiltration

24.4

23.6

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

23.4

179

824

R03BB04

ATC

tiotropium bromide; inhalant

2.9

23.4

125

481

N02AA05

ATC

oxycodone; systemic

2.4

23.4

190

899

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

25.5

23.2

M05BB03

ATC

alendronic acid and colecalciferol; oral

5.9

23.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.2

23.0

326

SPAT1229

SPAT

Assessment of need for aid

3.3

22.6

297

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

22.6

255

1385

N19

ICD-10 Finland

Unspecified kidney failure

4.8

22.5

114

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

22.0

164

744

RS220, ,

NOMESCO Finland

7.3

21.7

A12BA01

ATC

potassium chloride; oral

4.6

21.6

122

H26.9

ICD-10 Finland

Cataract, unspecified

6.6

21.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

6.2

21.4

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

21.3

165

762

R60.0

ICD-10 Finland

Localized oedema

2.6

21.2

134

562

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

17.1

21.1

TK820

NOMESCO Finland

Peritoneal dialysis

22.1

20.9

L04AB01

ATC

etanercept; parenteral

7.5

20.9

A07EA06

ATC

budesonide; oral, local oral

4.2

20.8

143

7151

FHL

Kidney transplantation

214.9

20.7

R06.0

ICD-10 Finland

Dyspnoea

2.1

20.6

270

1546

H05AA02

ATC

teriparatide; parenteral

26.2

20.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.8

20.4

182

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

5.1

20.4

H05BX01

ATC

cinacalcet; oral

16.6

20.2

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

20.1

240

1323

318

Kela drug reimbursment

Teriparatide

24.1

20.0

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

24.1

20.0

XG466

NOMESCO Finland

Sleep oxymetry

4.5

19.9

117

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.8

19.9

106

406

C08CA01

ATC

amlodipine; oral

2.0

19.8

363

2332

J01CF02

ATC

cloxacillin; systemic

5.7

19.8

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

107.5

19.6

M81.4

ICD-10 Finland

Drug-induced osteoporosis

25.3

19.6

D86.0

ICD-10 Finland

Sarcoidosis of lung

7.3

19.6

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.5

19.6

135

589

J96.1

ICD-10 Finland

Chronic respiratory failure

5.8

19.6

JN4AD

NOMESCO Finland

Body CT examination

2.7

19.5

119

489

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

19.4

S01EC04

ATC

brinzolamide; ophthalmic

4.1

19.3

142

XCH00

NOMESCO Finland

Eye pressure measurement

3.8

19.3

170

114

Kela drug reimbursment

Glaucoma

3.0

19.2

338

RD210, ,

NOMESCO Finland

5.8

19.1

K65.0

ICD-10 Finland

Acute peritonitis

15.3

19.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.2

19.0

263

WX199

NOMESCO Finland

Other local analgesia

4.5

18.9

109

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.1

18.8

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

7.9

18.8

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.2

18.7

R03BB01

ATC

ipratropium bromide; inhalant

4.3

18.7

123

A02BC01

ATC

omeprazole; systemic

2.0

18.6

262

1529

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

39.3

18.6

C07AG02

ATC

carvedilol; oral

3.2

18.5

267

A10AC01

ATC

insulin (human); parenteral

2.9

18.4

329

J05AB11

ATC

valaciclovir; oral

2.3

18.4

164

802

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

8.0

18.4

E000001, ,

ATC

2.1

18.4

201

1068

TNG10

NOMESCO Finland

Puncture of knee

7.3

18.3

L04AA17

ATC

[U] adalimumab

45.0

18.3

Z94.2

ICD-10 Finland

Lung transplant status

45.0

18.3

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.4

18.1

C09AA02

ATC

enalapril; systemic

2.2

18.0

187

972

J45.1

ICD-10 Finland

Nonallergic asthma

2.9

18.0

333

M45

ICD-10 Finland

Ankylosing spondylitis

5.0

17.9

C08CA03

ATC

isradipine; systemic

7.8

17.9

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

68.1

17.8

J01DB01

ATC

cefalexin; oral

2.4

17.7

745

6242

ZX108

NOMESCO Finland

Inhalation

15.0

17.7

H40.0

ICD-10 Finland

Glaucoma suspect

2.9

17.7

342

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

17.7

120

519

R03DC01

ATC

zafirlukast; oral

6.0

17.5

J01FA06

ATC

roxithromycin; oral

1.9

17.5

379

2544

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

29.5

17.5

C02EA02, ,

ATC

4.2

17.3

117

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.5

17.2

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

17.2

147

705

M10.9

ICD-10 Finland

Gout, unspecified

3.1

17.1

252

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

51.1

17.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

5.8

16.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

16.9

337

2199

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.2

16.8

115

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.1

16.7

116

L04AA05

ATC

[U] tacrolimus

91.9

16.6

Z99.2

ICD-10 Finland

Dependence on renal dialysis

173.2

16.5

S01EE03

ATC

bimatoprost; ophthalmic

5.1

16.5

SPAT1263

SPAT

Sampling

1.8

16.5

382

2605

R03BA02

ATC

budesonide; inhalant

2.1

16.5

189

1018

J45.8

ICD-10 Finland

Mixed asthma

4.2

16.3

109

SPAT1262

SPAT

Handing over of treatment supplies

2.1

16.3

175

919

B01AA03

ATC

warfarin; systemic

2.2

16.3

158

797

Z3229

NOMESCO Finland

Other healthcare associate professional

2.7

16.3

357

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.9

16.3

293

C03DA01

ATC

spironolactone; oral

2.4

16.2

122

552

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

30.7

16.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

30.7

16.2

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.1

16.1

182

974

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

16.1

158

801

ZX112

NOMESCO Finland

Subcutaneous

4.5

16.0

SPAT1254

SPAT

Administration of medicine

2.3

16.0

141

683

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

16.0

167

I50.9

ICD-10 Finland

Heart failure, unspecified

2.4

15.8

116

519

D64.9

ICD-10 Finland

Anaemia, unspecified

2.6

15.8

411

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

61.2

15.8

WZA10

NOMESCO Finland

Extensive medical or dental certificate

6.0

15.8

R4110

NOMESCO Finland

Physiotherapy

1.9

15.8

272

1686

K83.0

ICD-10 Finland

Cholangitis

7.0

15.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

15.7

310

TQW99

NOMESCO Finland

Other minor procedure on skin

3.1

15.7

221

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

15.7

494

3675

M13.9

ICD-10 Finland

Arthritis, unspecified

2.7

15.7

346

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

86.7

15.6

K06.18

ICD-10 Finland

Another gingival hyperplasia

22.5

15.6

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

4.6

15.5

L01BB01, ,

ATC

162.8

15.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

15.5

189

1039

EBA10

NOMESCO Finland

Operative extraction of tooth

2.4

15.5

119

543

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

15.5

133

638

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

6.8

15.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

16.4

15.3

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

15.3

279

1759

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

29.2

15.2

A41.8

ICD-10 Finland

Other specified sepsis

5.4

15.2

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.5

15.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

15.1

375

2592

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.5

15.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.3

15.0

179

R03AC03

ATC

terbutaline; inhalant

2.2

15.0

143

715

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

15.0

114

518

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

15.0

403

A10AB05

ATC

insulin aspart; parenteral

2.7

15.0

330

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.3

14.9

190

J05AB01

ATC

aciclovir; systemic

2.0

14.9

214

1245

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.9

14.8

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.7

14.8

J01EA01

ATC

trimethoprim; systemic

1.9

14.7

236

1423

M05BA01

ATC

etidronic acid; systemic

18.8

14.7

H02AB08

ATC

triamcinolone; systemic

21.5

14.7

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

14.6

279

1779

C02AC05

ATC

moxonidine; oral

3.3

14.5

178

JJC00

NOMESCO Finland

Allogenic transplantation of liver

36.7

14.5

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.5

14.4

148

S18

ICPC

Laceration/cut

1.8

14.4

416

2990

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

14.4

143

726

A06AD11

ATC

lactulose; oral

2.2

14.4

134

663

R03DC03

ATC

montelukast; oral

2.0

14.4

172

937

212

Kela drug reimbursment

Gout

6.1

14.4

AA1AD

NOMESCO Finland

CT of head and brain

1.9

14.3

246

1515

M05BA06

ATC

ibandronic acid; systemic

4.8

14.3

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.8

14.3

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

27.7

14.3

WZC30

NOMESCO Finland

Teaching

2.1

14.3

159

843

JN4BD

NOMESCO Finland

Extensive body CT

2.3

14.3

113

522

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

14.3

335

2268

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

22.7

14.3

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

6.3

14.3

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

5.8

14.2

XW000

NOMESCO Finland

Bone marrow biopsy

3.4

14.2

160

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.4

14.2

155

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

12.2

14.1

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

43.2

14.1

A07EC02

ATC

mesalazine; oral, rectal

3.0

14.1

235

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.8

14.1

269

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

6.8

14.1

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

6.0

14.1

J01DA01

ATC

[U] cefalexin

1.8

14.0

546

4257

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

14.0

299

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.8

14.0

282

H43.1

ICD-10 Finland

Vitreous haemorrhage

4.4

13.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

13.9

336

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.5

13.9

C07AB07

ATC

bisoprolol; oral

1.7

13.9

421

3058

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

13.9

203

1186

V03AE03

ATC

lanthanum carbonate; oral

24.2

13.8

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

3.0

13.8

210

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

5.4

13.8

R4190

NOMESCO Finland

Nutritional therapy

3.4

13.7

158

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

13.7

183

1035

R11

ICD-10 Finland

Nausea and vomiting

2.5

13.6

389

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

76.4

13.6

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

76.4

13.6

Z3226

NOMESCO Finland

Physiotherapist

2.0

13.6

183

1038

H16.9

ICD-10 Finland

Keratitis, unspecified

5.6

13.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

13.5

287

RS221, ,

NOMESCO Finland

5.3

13.5

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

16.5

13.5

S01AX11

ATC

[U] ofloxacin

3.8

13.5

111

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.8

13.5

111

N03AX16

ATC

[U] pregabalin

1.9

13.5

230

1410

ZY010

NOMESCO Finland

Hospital outpatient

2.9

13.5

230

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.8

13.4

276

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.5

13.4

H15.1

ICD-10 Finland

Episcleritis

5.7

13.4

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

5.0

13.4

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

21.5

13.4

C08CA13

ATC

lercanidipine; oral

2.1

13.4

141

732

CKC12

NOMESCO Finland

Photocoagulation of retina

3.3

13.3

161

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

13.2

113

539

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.7

13.2

296

A02BA02

ATC

ranitidine; systemic

1.9

13.2

183

1048

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

40.7

13.2

GDG10

NOMESCO Finland

Bilateral transplantation of lung

40.7

13.2

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

15.3

13.1

B01AB05

ATC

enoxaparin; parenteral

1.8

13.1

287

1895

N30.0

ICD-10 Finland

Acute cystitis

2.1

13.0

144

760

S01EA03

ATC

apraclonidine; ophthalmic

10.3

13.0

WX204

NOMESCO Finland

Axillary plexus blockaced

3.4

13.0

143

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

22.9

12.9

X58

ICD-10 Finland

Exposure to other specified factors

2.0

12.8

147

786

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

14.3

12.8

WX882

NOMESCO Finland

High dependency care

3.8

12.8

106

TQW80

NOMESCO Finland

Local dermatologic skincare

4.1

12.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

12.7

136

710

NHQ40

NOMESCO Finland

Amputation of toe

5.6

12.6

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

70.9

12.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

12.6

323

2225

321

Kela drug reimbursment

Paricalcitol and cinacalcet

11.2

12.6

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

12.5

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

24.7

12.5

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

20.4

12.5

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.9

12.5

217

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

13.4

12.5

S01EE01

ATC

latanoprost; ophthalmic

2.8

12.4

240

J02AC01

ATC

fluconazole; systemic

1.7

12.4

352

2488

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

12.3

222

1379

K51.8

ICD-10 Finland

Other ulcerative colitis

5.2

12.3

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.6

12.2

114

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

38.1

12.2

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

38.1

12.2

N28

ICPC

Limited function/disability (N)

5.6

12.2

P01AB01

ATC

metronidazole; oral, rectal

1.7

12.1

361

2583

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

12.0

268

WX892

NOMESCO Finland

Monitored bed care

2.5

12.0

354

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.2

12.0

161

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

12.0

109

533

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

12.0

393

R31

ICD-10 Finland

Unspecified haematuria

2.3

12.0

426

ZXE00

NOMESCO Finland

One hour or less

1.7

11.9

343

2427

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.2

11.9

A02BC05

ATC

esomeprazole; systemic

1.7

11.9

372

2692

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.3

11.8

142

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

11.7

196

R03AK03

ATC

[U] fenoterol and ipratropium bromide

3.0

11.7

185

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5.0

11.7

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

4.6

11.7

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

4.7

11.7

B02.9

ICD-10 Finland

Zoster without complication

2.6

11.7

278

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

11.7

266

N03AX12

ATC

[U] gabapentin; oral

1.9

11.7

165

948

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.4

11.6

128

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.2

11.6

154

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

5.8

11.5

SPAT1255

SPAT

Intravenous administration of medicine

2.6

11.5

274

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

13.8

11.5

J01CA04

ATC

amoxicillin; systemic

1.9

11.5

713

6156

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.9

11.5

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

+∞

11.5

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

121.6

11.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

11.4

124

649

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.5

11.4

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.5

11.4

SPAT1211

SPAT

Application of soft bandage

2.3

11.4

402

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.0

11.4

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

11.3

301

WX202

NOMESCO Finland

Supraclavicular plexus blockade

5.0

11.3

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

11.3

253

I15.0

ICD-10 Finland

Renovascular hypertension

17.3

11.2

L04AA11

ATC

[U] etanercept

17.3

11.2

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

11.2

272

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

11.2

163

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.3

11.1

R4180

NOMESCO Finland

Podiatric therapy

5.3

11.1

KBV00

NOMESCO Finland

Insertion of stent into ureter

11.3

11.1

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.3

11.1

127

B01AB04

ATC

dalteparin; parenteral

2.9

11.0

186

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.0

11.0

170

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

43.9

10.9

A02BC03

ATC

lansoprazole; oral

1.7

10.9

262

1758

A03FA01

ATC

metoclopramide; systemic, rectal

1.8

10.9

205

1284

H3603, E103,

ICD-10 Finland

15.7

10.9

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.1

10.8

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.2

10.8

134

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

9.8

10.8

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

5.0

10.8

R06AE07

ATC

cetirizine; oral

1.6

10.8

381

2822

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

10.8

183

CKD40

NOMESCO Finland

Endophotocoagulation of retina

4.8

10.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

10.7

241

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

28.4

10.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.6

10.7

253

SPAT1216

SPAT

Assessment of functional ability

2.0

10.7

134

737

KAC00

NOMESCO Finland

Nephrectomy

21.8

10.7

N04.9

ICD-10 Finland

Nephrotic syndrome, unspecified

60.8

10.6

JJ5AT, ,

NOMESCO Finland

60.8

10.6

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.1

10.6

102

509

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.4

10.6

J01MA01

ATC

ofloxacin; systemic

2.3

10.6

355

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

11.4

10.6

S01KA02

ATC

hypromellose; ophthalmic

4.4

10.6

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.1

10.6

D11AH01

ATC

tacrolimus; topical

9.3

10.5

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

3.6

10.5

101

H25.0

ICD-10 Finland

Senile incipient cataract

2.6

10.5

262

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

10.5

318

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

111.3

10.4

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

111.3

10.4

N04.0

ICD-10 Finland

Nephrotic syndrome, minor glomerular abnormality

+∞

10.4

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

+∞

10.4

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

3.2

10.4

132

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

10.4

194

1211

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.3

10.4

378

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

16.3

10.4

6BA02, ,

NOMESCO Finland

16.3

10.4

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

8.3

10.4

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.6

10.3

234

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

8.9

10.3

SPAT1325

SPAT

Vaccination

1.7

10.3

281

1947

5AB14, ,

NOMESCO Finland

23.7

10.3

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

23.7

10.3

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

10.3

188

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

10.2

482

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

10.2

329

2374

A02BA03

ATC

famotidine; systemic

3.1

10.2

139

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.7

10.2

R03AC02

ATC

salbutamol; inhalant

1.6

10.1

481

3803

R03BA08

ATC

ciclesonide; inhalant

2.2

10.1

436

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

10.1

114

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.6

10.1

231

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

40.6

10.0

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

40.6

10.0

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

40.6

10.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

10.0

177

1088

N05CF01

ATC

zopiclone; oral

1.6

9.9

277

1927

M31.3

ICD-10 Finland

Wegener granulomatosis

16.9

9.9

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.6

9.8

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

8.9

9.8

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

3.5

9.8

101

K51.5

ICD-10 Finland

Left sided colitis

3.4

9.8

106

D06BB04

ATC

podophyllotoxin; topical

2.8

9.8

187

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

9.8

148

N02AC04

ATC

dextropropoxyphene; oral

3.1

9.8

132

Z3231

NOMESCO Finland

Registered nurse

1.7

9.8

243

1640

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

9.7

291

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

13.6

9.7

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.4

9.7

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.4

9.7

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.4

9.7

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

55.6

9.7

XPX08

NOMESCO Finland

Intraoperative flow measurement

7.9

9.7

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

7.9

9.7

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.0

9.6

E86

ICD-10 Finland

Volume depletion

4.0

9.6

L57.0

ICD-10 Finland

Actinic keratosis

2.1

9.6

472

K50.8

ICD-10 Finland

Other Crohn disease

4.4

9.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

9.6

145

847

NDG30

NOMESCO Finland

Fusion of wrist, total

11.5

9.6

ZXD20

NOMESCO Finland

Day surgery

1.9

9.6

121

667

A28

ICPC

Limited function/disability NOS

1.9

9.6

131

742

WX872

NOMESCO Finland

Intensive care

2.6

9.6

213

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

15.2

9.5

A01AB09

ATC

miconazole; local oral

2.2

9.5

412

QXB99, ,

SPAT

3.8

9.5

5602

FHL

Internal fistula (eg Cimino)

101.1

9.4

M32

ICD-10 Finland

Systemic lupus erythematosus

101.1

9.4

187

Kela drug reimbursment

MPA

101.1

9.4

H05BX02

ATC

paricalcitol; systemic

101.1

9.4

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

17.8

9.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

9.4

395

3017

PC6DE, ,

NOMESCO Finland

+∞

9.4

M31.1

ICD-10 Finland

Thrombotic microangiopathy

+∞

9.4

S01FA02

ATC

scopolamine; ophthalmic

8.2

9.4

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

9.4

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

9.4

180

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

4.6

9.3

1XC02, ,

NOMESCO Finland

10.8

9.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

9.3

222

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

9.3

161

981

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

9.3

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.2

9.3

115

SAA04

NOMESCO Finland

Special examination of mouth

2.5

9.3

253

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.4

9.3

J01CA08

ATC

pivmecillinam; oral

1.6

9.3

329

2417

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.4

9.2

260

TQW40

NOMESCO Finland

Remowal of suture of skin

2.3

9.2

324

L84

ICD-10 Finland

Corns and callosities

3.0

9.1

132

A01AB10

ATC

natamycin; local oral

3.4

9.1

101

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.4

9.1

A04AA01

ATC

ondansetron; systemic, rectal

2.2

9.1

399

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

11.6

9.1

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

9.2

9.1

602

Kela drug reimbursment

Children's severe malnutrition

15.8

9.0

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

37.1

9.0

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

37.1

9.0

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

37.1

9.0

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

9.0

199

1298

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.5

9.0

N30.9

ICD-10 Finland

Cystitis, unspecified

2.5

9.0

232

N06AA09

ATC

amitriptyline; systemic

2.0

9.0

499

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

8.9

404

3126

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.2

8.9

368

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.8

8.9

156

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

24.3

8.9

L28

ICPC

Limited function/disability (L)

1.8

8.9

145

867

49300

ICD-8 Finland

Asthma, bronchiale

3.7

8.9

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

12.7

8.9

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

12.7

8.9

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

6.9

8.9

J45

ICD-10 Finland

Asthma

2.0

8.9

501

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

5.0

8.9

KBV10

NOMESCO Finland

Removal of stent from ureter

8.7

8.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.5

8.8

216

K92.1

ICD-10 Finland

Melaena

2.6

8.8

198

SPAT1234

SPAT

Support of social functional capacity

2.8

8.8

169

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.6

8.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

8.7

117

658

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

14.2

8.7

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

8.7

V03AG01

ATC

sodium cellulose phosphate; systemic

50.5

8.7

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

50.5

8.7

M01AE01

ATC

ibuprofen; systemic, rectal

0.6

8.7

641

7137

R06.2

ICD-10 Finland

Wheezing

2.7

8.7

170

A07DA03

ATC

loperamide; oral

3.1

8.7

120

N06AB04

ATC

citalopram; systemic

1.7

8.7

182

1170

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

8.7

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

4.5

8.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

8.6

J01CF05

ATC

flucloxacillin; systemic

2.3

8.6

287

S01EE05

ATC

tafluprost; ophthalmic

2.9

8.6

142

E87.5

ICD-10 Finland

Hyperkalaemia

4.6

8.6

L04AB06

ATC

golimumab; parenteral

8.3

8.6

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.0

8.6

126

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

8.6

269

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.5

8.6

219

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

10.2

8.5

H35.36

ICD-10 Finland

Macular cyst

10.2

8.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

8.5

110

610

H33.0

ICD-10 Finland

Retinal detachment with retinal break

3.0

8.5

132

L95

ICPC

Osteoporosis

2.8

8.5

149

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

20.3

8.5

A10BH05

ATC

linagliptin; oral

2.6

8.5

196

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

3.3

8.4

C90.0

ICD-10 Finland

Multiple myeloma

6.8

8.4

Z94.1

ICD-10 Finland

Heart transplant status

12.9

8.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

8.4

343

2588

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

+∞

8.3

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.7

8.3

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

8.6

8.3

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.8

8.3

143

868

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

8.2

169

R01AD08

ATC

fluticasone; nasal

1.6

8.2

245

1718

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.7

8.2

175

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

8.2

381

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

3.6

8.2

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

4.6

8.1

RS222, ,

NOMESCO Finland

4.8

8.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.7

8.1

156

977

S01EC03

ATC

dorzolamide; ophthalmic

8.2

8.1

NB1AD

NOMESCO Finland

Shoulder CT examination

4.1

8.1

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.0

8.1

125

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

33.7

8.1

L04AA10

ATC

[U] sirolimus

33.7

8.1

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

33.7

8.1

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

33.7

8.1

NDB60

NOMESCO Finland

Prosthetic replacement of MCP joint of finger

17.4

8.1

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

17.4

8.1

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

17.4

8.1

SPAT1153

SPAT

Removal of sutures

1.6

8.1

268

1926

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

9.0

8.1

C02DE02, ,

ATC

10.2

8.0

J01MA06

ATC

norfloxacin; oral

1.9

8.0

114

652

M33.2

ICD-10 Finland

Polymyositis

22.3

8.0

B01.9

ICD-10 Finland

Varicella without complication

22.3

8.0

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

22.3

8.0

Z2221

NOMESCO Finland

Medical doctor

1.6

7.9

231

1609

J01FA10

ATC

azithromycin; systemic

1.5

7.9

488

3995

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

7.9

471

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.7

7.9

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

7.9

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

7.9

457

J01CF01

ATC

dicloxacillin; systemic

13.2

7.9

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.7

7.9

167

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

7.8

340

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

10.9

7.8

RJ411, ,

NOMESCO Finland

9.5

7.8

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

7.8

361

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

7.8

168

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.1

7.8

101

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

6.4

7.7

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.8

7.7

134

NDG74

NOMESCO Finland

Fusion of first IP joint

15.2

7.7

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

7.7

276

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

7.6

231

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

7.6

242

1718

WX212

NOMESCO Finland

Femoral plexus blockade

3.7

7.6

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.8

7.6

L73.8

ICD-10 Finland

Other specified follicular disorders

6.8

7.6

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.2

7.6

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

12.0

7.6

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

7.6

264

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

25.2

7.6

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.3

7.6

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

9.0

7.6

J20

ICD-10 Finland

Acute bronchitis

1.9

7.6

515

R03BA05

ATC

fluticasone; inhalant

1.7

7.6

160

1028

D02AX

ATC

Other emollients and protectives

2.9

7.6

119

TAB00

NOMESCO Finland

Lumbar puncture

2.5

7.5

195

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

7.5

195

S86.0

ICD-10 Finland

Injury of Achilles tendon

3.2

7.5

M10.0

ICD-10 Finland

Idiopathic gout

3.0

7.5

109

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

4.5

7.5

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

4.5

7.5

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.3

7.4

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

80.8

7.4

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

80.8

7.4

KAS40

NOMESCO Finland

Excision of transplanted kidney

80.8

7.4

M31.7

ICD-10 Finland

Microscopic polyangiitis

80.8

7.4

K06.10

ICD-10 Finland

Gingival fibromatosis

80.8

7.4

4059B

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]

80.8

7.4

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

7.7

7.4

M01CB03

ATC

auranofin; oral

7.7

7.4

3AC01, ,

NOMESCO Finland

7.7

7.4

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

6.0

7.4

KA3EB

NOMESCO Finland

Antegrade pyelography

13.5

7.4

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

7.4

161

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

7.4

390

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

7.4

173

D06BB10

ATC

imiquimod; topical

2.4

7.3

210

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.9

7.3

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

+∞

7.3

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

9.5

7.3

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

7.3

114

672

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.9

7.3

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.3

7.3

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

7.3

399

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

7.3

500

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.4

7.2

224

H25.2

ICD-10 Finland

Senile cataract, morgagnian type

15.9

7.2

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

3.7

7.2

NDL52

NOMESCO Finland

Tenosynovectomy of hand

7.4

7.2

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.0

7.2

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

3.0

7.2

106

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.6

7.2

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.9

7.2

117

D07AB08

ATC

desonide; topical

1.9

7.2

539

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

7.2

170

1124

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

30.3

7.2

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

20.2

7.1

K65.9

ICD-10 Finland

Peritonitis, unspecified

20.2

7.1

ZXD00

NOMESCO Finland

Emergency procedure

3.0

7.1

101

M81.8

ICD-10 Finland

Other osteoporosis

6.6

7.1

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.8

7.1

123

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

4.1

7.1

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.5

7.1

170

K03.66

ICD-10 Finland

Tooth plaque

2.1

7.1

360

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

7.1

109

639

S01EC54

ATC

brinzolamide, combinations; ophthalmic

5.7

7.1

XKD00

NOMESCO Finland

Uroflowmetry

1.8

7.1

113

670

L03AA02

ATC

filgrastim; parenteral

2.9

7.1

118

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.7

7.1

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

7.1

7.0

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.4

7.0

132

Kela drug reimbursment

Sarcoidosis

6.4

7.0

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

6.4

7.0

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

6.4

7.0

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

7.0

370

L01BB02

ATC

mercaptopurine; oral

5.9

6.9

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

13.9

6.9

L04AB05

ATC

certolizumab pegol; parenteral

13.9

6.9

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

6.9

479

S01AD03

ATC

aciclovir; ophthalmic

2.7

6.9

137

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.8

6.9

120

A01AB04

ATC

amphotericin B; local oral

2.4

6.8

198

A10AB01

ATC

insulin (human); parenteral

2.8

6.8

126

A10AE05

ATC

insulin detemir; parenteral

2.3

6.8

230

XX9XE

NOMESCO Finland

Other ultrasound examination

6.8

H01AC01

ATC

somatropin; parenteral

11.0

6.8

J01XX08

ATC

linezolid; systemic

9.4

6.8

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.7

6.8

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.2

6.8

277

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.3

6.8

ZX197, ,

NOMESCO Finland

40.4

6.8

N03.2

ICD-10 Finland

Chronic nephritic syndrome, diffuse membranous glomerulonephritis

40.4

6.8

NDL40

NOMESCO Finland

Repair of tendon of finger with transplant

16.8

6.8

ZXC50

NOMESCO Finland

Cryotherapy

2.9

6.7

110

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

3.4

6.7

J47

ICD-10 Finland

Bronchiectasis

3.4

6.7

121

Kela drug reimbursment

Severe hypofunction of sexual glands

3.4

6.7

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.2

6.7

R03AC04

ATC

fenoterol; inhalant

22.7

6.7

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

22.7

6.7

ZX199

NOMESCO Finland

Other rote

22.7

6.7

58209

ICD-8 Finland

Chronic nephritis, Unspecified

22.7

6.7

N04.2

ICD-10 Finland

Nephrotic syndrome, diffuse membranous glomerulonephritis

22.7

6.7

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

6.7

433

J01DC02

ATC

cefuroxime; systemic

2.3

6.7

239

S51.0

ICD-10 Finland

Open wound of elbow

5.5

6.6

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

6.0

6.6

WX890

NOMESCO Finland

Intesive care monitoring

7.9

6.6

H02AA02

ATC

fludrocortisone; oral

7.9

6.6

I82.88

ICD-10 Finland

Embolism and thrombosis of other specified veins

3.6

6.6

SPAT1301

SPAT

No procedures

1.5

6.6

244

1782

S19

ICPC

Skin injury other

2.6

6.6

146

CJE15

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy

12.4

6.6

ZQZ00

NOMESCO Finland

Treatment of several skin areas

12.4

6.6

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.4

6.6

189

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

4.2

6.6

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

4.2

6.6

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

10.1

6.5

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.8

6.5

112

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

6.9

6.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

6.5

173

1174

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.4

6.5

S76

ICPC

Skin infection other

2.3

6.5

216

TJF80

NOMESCO Finland

Ostomy education

5.8

6.5

XF602

NOMESCO Finland

Bloodpressure monitoring

5.8

6.5

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

4.0

6.5

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

4.0

6.5

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.0

6.5

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.3

6.5

R06AX22

ATC

ebastine; oral

1.6

6.5

144

936

WW302

NOMESCO Finland

Allogenic transfer of stem cells from relative

70.4

6.4

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

70.4

6.4

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

70.4

6.4

9531

FHL

Arthrodesis of the hand joint

14.4

6.4

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

14.4

6.4

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

14.4

6.4

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

14.4

6.4

S01EE04

ATC

travoprost; ophthalmic

3.8

6.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

6.4

102

605

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

6.6

6.4

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

6.6

6.4

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

6.6

6.4

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

3.6

6.3

R03BA01

ATC

beclometasone; inhalant

1.7

6.3

111

676

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

6.3

251

K11.2

ICD-10 Finland

Sialoadenitis

2.8

6.3

114

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

3.2

6.3

QBA10

NOMESCO Finland

Incision of skin of trunk

5.6

6.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.0

6.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

6.3

215

1542

H34.8

ICD-10 Finland

Other retinal vascular occlusions

3.4

6.3

D68.9

ICD-10 Finland

Coagulation defect, unspecified

11.1

6.3

C08DA01

ATC

verapamil; systemic

2.4

6.3

174

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

6.3

320

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.9

6.3

78900

ICD-8 Finland

Abnormal urinary constituents of unspecified cause, Albuminuria

18.2

6.3

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

+∞

6.3

BE00A, ,

NOMESCO Finland

+∞

6.3

4059A

ICD-9 Finland

Secondary hypertension, Unspecified[HYPERTONIA RENOVASCULARIS]

+∞

6.3

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

6.3

7101

FHL

Needle biopsy in the operating room

+∞

6.3

4AA09, ,

NOMESCO Finland

+∞

6.3

9968A

ICD-9 Finland

Complications peculiar to certain specified procedures, Complications of transplanted organ

+∞

6.3

TCH12

NOMESCO Finland

Sample aspiration from anterior chambre

+∞

6.3

S70

ICPC

Herpes zoster

2.9

6.3

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

26.9

6.2

S01FA06

ATC

tropicamide; ophthalmic

26.9

6.2

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

6.2

104

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

5.1

6.2

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.0

6.2

C09CA01

ATC

losartan; oral

1.5

6.2

206

1469

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.6

6.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.3

6.2

-, ,

ICD-10 Finland

3.3

6.2

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

5.4

6.2

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.8

6.2

110

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.1

6.2

288

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

6.1

302

N20.1

ICD-10 Finland

Calculus of ureter

2.7

6.1

122

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.7

6.1

122

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

4.2

6.1

J37.0

ICD-10 Finland

Chronic laryngitis

2.6

6.1

140

XX4BW, ,

NOMESCO Finland

12.6

6.1

RS311, ,

NOMESCO Finland

12.6

6.1

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.6

6.1

B03BA03

ATC

hydroxocobalamin; parenteral

2.3

6.1

190

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

6.8

6.0

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

10.1

6.0

M35.1

ICD-10 Finland

Other overlap syndromes

10.1

6.0

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

6.0

304

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

6.0

159

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.7

6.0

123

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

3.4

6.0

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

6.0

129

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3010375) cycloSPORINE [Mass/volume] in Blood

111

48.80

188.61

34.3

28.1

111.54

141.62

ug/l

0.98

101

(3026250) Tacrolimus [Mass/volume] in Blood

111

38.42

177.33

38.2

31.8

7.26

7.28

ug/l

0.01

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

150

12.65

149.34

16.6

6.7

662.63

194.21

iu/ml

1.08

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

135

113

13.96

137.83

7.1

3.2

325.62

749.30

u/ml

—

(3020779) Urea [Moles/volume] in Serum or Plasma

268

613

5.88

116.84

27.2

7.1

11.91

8.96

mmol/l

5.15

260

586

(3003458) Phosphate [Moles/volume] in Serum or Plasma

322

944

4.83

103.36

22.1

5.5

1.10

1.05

mmol/l

2.59

309

876

(3042733) HLA Ab [Presence] in Serum

29.19

96.24

5.2

4.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

669

3498

4.96

95.22

19.8

6.3

—

(40768446) Kidney Pathology biopsy report

24.15

89.79

2.4

1.5

—

(3006315) Basophils [#/volume] in Blood

678

3714

4.76

87.07

17.8

5.8

0.04

e9/l

0.25

638

3207

(3001604) Monocytes [#/volume] in Blood

676

3707

4.71

86.37

17.8

5.8

0.61

0.58

e9/l

3.24

634

3195

(3013115) Eosinophils [#/volume] in Blood

686

3835

4.75

84.48

18.7

6.2

0.18

0.19

e9/l

1.02

641

3369

(3019198) Lymphocytes [#/volume] in Blood

680

3788

4.66

83.87

18.1

5.9

1.78

1.95

e9/l

2.62

646

3351

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

107

134

8.97

81.41

2.5

1.5

117.25

109.21

u/ml

0.32

(3005719) IgG [Mass/volume] in Serum or Plasma

222

577

4.82

80.90

6.3

2.7

8.93

10.46

g/l

5.57

214

528

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

112

153

8.26

79.29

2.5

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

215

554

4.83

79.06

10.8

3.9

148.09

80.40

ng/l

3.51

196

497

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

131

219

6.87

77.25

14.6

3.8

1.96

1.42

mg/l

5.64

126

201

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

11.80

74.85

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

254

777

4.21

74.28

6.5

4.5

242.25

249.61

u/l

0.26

244

738

(3006504) Eosinophils/100 leukocytes in Blood

631

3504

3.92

73.95

18.8

6.0

2.60

2.93

3.30

607

3288

(3019069) Monocytes/100 leukocytes in Blood

633

3523

3.93

73.91

19.5

6.3

8.76

8.62

0.55

610

3311

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

11.34

73.75

2.5

2.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

197

502

4.78

73.05

13.2

3.9

4.95

5.15

kpa

2.77

192

485

(3009343) pH of Capillary blood

195

495

4.79

72.62

13.3

3.9

7.41

7.42

0.04

(3022096) Basophils/100 leukocytes in Blood

615

3390

3.79

72.16

18.9

6.0

0.69

0.70

0.16

594

3173

(3018010) Neutrophils/100 leukocytes in Blood

632

3547

3.87

72.07

17.7

5.9

59.56

56.45

9.01

609

3341

(3002030) Lymphocytes/100 leukocytes in Blood

637

3601

3.88

71.65

19.0

6.1

25.82

28.49

9.03

616

3390

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

190

480

4.79

71.09

13.2

3.9

1.00

1.95

mmol/l

2.73

153

365

(3007853) Bacteria identified in Skin by Aerobe culture

260

836

4.01

70.55

2.7

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

300

1065

3.77

70.44

6.2

2.4

11.75

13.31

umol/l

3.84

291

994

(3042936) Bacteria identified in Isolate by Culture

294

1045

3.74

68.68

3.6

2.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

106

160

7.41

68.53

2.0

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

20.09

67.99

3.1

2.2

47024.21

88660.80

u/ml

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

700

4291

4.25

67.89

23.3

9.3

4.41

3.99

e9/l

5.41

667

3747

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

304

1113

3.66

67.77

3.1

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

186

480

4.66

67.55

2.6

1.6

—

(3023368) Bacteria identified in Blood by Culture

419

1892

3.35

66.47

8.5

4.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

9.13

64.45

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

100

152

7.30

64.15

2.0

1.3

302.35

273.31

u/ml

0.31

(3024471) HLA-A [Type]

22.03

64.14

1.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

277

985

3.66

64.10

6.4

2.3

2.21

2.35

g/l

3.71

267

917

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

265

921

3.70

63.42

6.7

2.4

22.76

23.17

0.15

244

795

(3024932) HLA-DR beta [Type]

21.55

62.24

1.1

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

9.09

60.47

1.1

1.2

—

(3022313) Gas panel - Capillary blood

153

370

4.81

59.86

14.3

4.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

173

468

4.37

58.64

2.8

1.7

1.23

1.32

g/l

0.27

162

428

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

573

3276

3.20

57.93

21.9

6.0

1.22

1.21

mmol/l

1.42

539

2996

(3008757) Leukocyte morphology finding [Identifier] in Blood

9.46

57.74

5.0

4.0

—

(3017181) Myelocytes/100 leukocytes in Blood

200

611

3.95

57.31

7.7

4.2

0.62

0.98

1.97

125

219

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

112

214

5.86

57.23

4.1

3.0

0.27

0.35

u/ml

1.67

109

(3027945) Reticulocytes/100 erythrocytes in Blood

227

757

3.71

57.21

5.9

2.6

1.85

1.81

0.23

208

683

(3023520) Reticulocytes [#/volume] in Blood

187

550

4.06

56.47

5.1

2.7

71.39

72.38

e9/l

0.13

151

413

(3002179) Metamyelocytes/100 leukocytes in Blood

187

551

4.05

56.31

7.2

4.1

0.61

0.01

115

180

(3012095) Magnesium [Moles/volume] in Serum or Plasma

297

1193

3.26

55.48

11.1

3.4

0.80

0.82

mmol/l

1.69

284

1122

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

601

3597

3.18

54.75

25.8

6.7

1.22

mmol/l

0.12

541

3088

(3024561) Albumin [Mass/volume] in Serum or Plasma

542

3075

3.03

54.15

14.7

4.7

34.30

35.86

g/l

8.64

515

2871

(3021440) Promyelocytes/100 leukocytes in Blood

189

577

3.91

53.98

7.8

4.3

0.04

0.14

1.94

113

184

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

125

282

5.01

52.91

2.1

2.0

1.46

1.53

g/l

0.32

111

247

(3017143) Hepatitis C virus Ab [Presence] in Serum

224

778

3.53

52.64

2.7

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

534

3037

2.97

52.53

4.5

2.3

78.85

77.36

nmol/l

0.61

496

2710

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

131

6.99

52.42

3.6

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

131

6.99

52.42

3.6

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

131

317

4.69

50.87

2.9

1.4

27.98

6.08

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

112

243

5.14

49.52

2.0

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

182

5.81

49.28

3.7

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

186

5.68

48.13

3.6

1.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

106

227

5.18

47.53

2.0

1.6

0.73

0.09

iu/ml

0.72

(3026493) Urate [Moles/volume] in Serum or Plasma

383

1901

2.81

47.48

6.9

2.6

2351.78

7085.45

umol/l

1.95

356

1666

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

108

238

5.04

46.83

3.1

1.5

0.21

0.24

g/l

1.70

102

225

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

7.85

46.35

3.1

1.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

356

1721

2.81

46.16

3.3

2.1

3.60

3.05

mg/l

3.26

317

1469

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

109

247

4.90

45.69

3.1

1.5

1.14

1.21

g/l

1.33

103

233

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

137

6.33

45.52

3.5

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

239

940

3.13

45.09

2.7

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

320

1478

2.84

45.08

6.6

2.4

4.52

5.30

e6/l

0.48

301

1338

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

113

268

4.70

44.80

3.4

1.9

—

(3019225) pH of Specimen

201

720

3.33

44.30

12.6

4.1

—

(3025159) Blasts/100 leukocytes in Blood

169

546

3.60

43.79

7.4

4.3

0.01

0.71

0.64

150

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

9.97

43.68

1.5

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

355

1762

2.72

43.10

4.4

2.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

109

261

4.63

42.64

2.3

1.6

381.82

180.00

titre

0.40

(3002032) Base excess in Venous blood by calculation

191

679

3.32

42.48

14.9

3.6

1.26

1.95

mmol/l

1.76

169

554

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

7.88

42.46

3.2

1.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

458

2592

2.62

42.33

10.5

3.1

—

(3000991) Gas panel - Venous blood

179

613

3.42

42.27

17.0

8.8

—

(3037121) Protein [Mass/volume] in Urine

111

274

4.50

41.77

8.5

3.5

0.50

0.23

g/l

1.63

113

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

104

247

4.65

41.06

3.2

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

243

1011

2.95

41.05

1.7

1.3

680.57

498.28

titre

0.68

221

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

14.15

41.01

4.3

2.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

189

686

3.24

40.47

15.0

3.5

5.74

5.81

kpa

0.56

183

663

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

591

3841

2.68

40.12

14.2

6.5

9.77

11.14

umol/l

4.29

569

3654

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

102

249

4.51

38.85

2.7

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

164

562

3.36

38.45

3.3

2.9

64.90

66.96

g/l

2.78

156

513

(40761535) Cells panel - Urine sediment

165

569

3.35

38.28

8.9

3.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

8.19

38.22

1.5

1.3

2.59

2.68

g/l

0.11

(3024139) IgG subclass 3 [Mass/volume] in Serum

8.19

38.22

1.5

1.3

0.35

g/l

0.06

(3027135) IgG subclass 1 [Mass/volume] in Serum

8.19

38.22

1.5

1.3

5.90

6.85

g/l

0.59

(3036481) Cortisol [Moles/volume] in Serum or Plasma

185

686

3.16

38.03

3.6

2.2

272.47

367.55

nmol/l

7.58

176

640

(4062490) Immunoglobulin typing, IgG

7.95

37.29

1.5

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

185

4.98

37.21

2.1

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

525

3303

2.49

36.87

22.0

13.0

1.25

1.22

inr

0.24

137

956

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

6.73

36.27

3.1

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

6.73

36.27

3.1

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

228

4.50

36.04

3.7

2.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

148

497

3.38

35.70

1.8

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

751

5677

3.38

35.65

22.8

7.6

75.80

78.13

u/l

0.80

725

5334

(3024980) IgG subclass 4 [Mass/volume] in Serum

111

6.04

34.71

1.8

0.48

0.88

g/l

1.53

(3044640) Blood type and Crossmatch panel - Blood

403

2300

2.40

34.50

5.2

2.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

5.43

34.24

2.4

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

6.34

33.66

8.4

6.2

12.67

11.32

mg/l

1.44

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

12.16

33.57

3.4

2.0

61.18

71.19

ug/l

0.15

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

164

4.98

33.55

1.4

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

110

5.89

32.80

2.9

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

5.95

32.63

2.3

1.6

—

(3018418) pH of Serum or Plasma

376

2122

2.36

32.54

14.5

3.9

7.40

0.11

391

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

111

328

3.73

32.44

3.9

2.1

38.11

39.68

u/l

0.33

101

290

(3031040) Bacteria [#/volume] in Urine by Automated count

660

4761

2.61

32.29

10.3

4.2

56.58

1767.73

e6/l

0.95

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

102

286

3.91

32.14

2.7

1.9

2.96

2.37

ug/l

0.15

262

(3037467) Urinalysis macro (dipstick) panel - Urine

681

4999

2.67

31.89

12.8

4.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

717

5421

2.84

31.22

12.5

4.1

16.57

11.88

mm/h

11.59

671

5023

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

34.86

31.16

8.3

6.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

177

712

2.87

31.00

4.7

2.3

0.22

g/l

0.07

172

665

(3004588) Protein electrophoresis panel - Serum or Plasma

136

472

3.23

30.87

3.1

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

189

790

2.78

30.77

2.7

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

188

790

2.76

30.26

2.6

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

604

4246

2.39

30.24

12.7

4.7

6.61

6.67

mmol/l

0.37

586

3984

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

168

4.65

29.79

1.8

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

6.98

29.56

1.7

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

352

2008

2.27

28.88

4.8

3.0

1939.12

1043.26

ng/l

1.59

318

1686

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

389

2318

2.23

28.61

5.1

2.6

59.46

62.41

u/l

0.28

364

2140

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

118

396

3.29

28.21

1.8

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

100

5.69

28.21

1.9

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

236

1148

2.45

27.85

2.8

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

150

584

2.90

27.71

4.3

2.6

50.99

69.69

ml/min/173m2

6.50

231

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

102

5.58

27.61

1.9

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

102

5.58

27.61

1.9

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

378

2264

2.19

27.06

6.7

3.1

6.36

7.67

mmol/l

7.56

344

1913

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

6.45

26.85

3.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

6.45

26.85

3.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

6.45

26.85

3.4

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

101

5.52

26.84

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

101

5.52

26.84

2.0

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

6.57

26.75

3.1

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

467

3047

2.15

26.70

6.2

2.7

180.28

129.35

ug/l

2.76

440

2817

(3005988) Vibrio sp identified in Specimen by Organism specific culture

102

5.47

26.56

2.0

1.4

—

(3012516) Albumin [Mass/volume] in Urine

356

2097

2.18

26.43

6.2

3.2

589.96

208.79

mg/l

0.78

271

1312

(3037692) Legionella sp identified in Specimen by Organism specific culture

9.70

26.31

2.2

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

341

1985

2.18

25.99

8.3

3.0

0.22

0.44

e6/l

1.83

299

1494

(3018095) Leukocytes [#/volume] in Urine

409

2556

2.13

25.93

10.2

3.6

70.12

95.23

e6/l

0.38

340

1801

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

296

1630

2.24

25.90

2.6

1.8

1.48

1.16

mg/l

0.90

233

1250

(3000494) Fungus identified in Specimen by Culture

199

927

2.49

25.57

3.0

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

363

2177

2.15

25.52

9.1

3.1

27.17

60.62

e6/l

1.96

323

1670

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

5.86

25.46

3.4

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

502

3407

2.12

25.41

5.0

2.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

213

3.92

25.39

3.7

2.2

12.58

12.04

mg/l

0.20

194

(40758558) Short blood count panel - Blood

324

1863

2.18

25.34

13.8

6.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

240

1222

2.33

25.23

1.9

1.7

1189.68

1178.80

nmol/l

0.05

189

912

(3015377) Calcium [Moles/volume] in Serum or Plasma

391

2425

2.11

25.05

5.6

3.5

2.34

2.36

mmol/l

2.16

347

2143

(3030905) Polymorphonuclear cells [#/volume] in Blood

140

4.61

24.93

5.6

3.2

4.51

4.43

e9/l

0.08

140

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

145

4.53

24.76

6.2

3.5

59.68

57.86

0.48

145

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

363

2201

2.12

24.57

3.7

2.1

116.48

222.30

u/l

2.33

352

2077

(36304419) Bacteria [Presence] in Urine

332

1947

2.14

24.51

8.1

3.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

274

1490

2.23

24.50

2.3

1.5

2.38

g/l

0.01

204

890

(3036489) Thrombin time

276

3.48

24.02

3.9

2.2

21.84

21.57

0.22

256

(3020876) Protein [Mass/time] in 24 hour Urine

6.40

23.81

2.8

2.3

1.40

1.64

g/24h

0.22

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

20.21

23.61

1.4

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

8.60

23.24

1.8

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

8.60

23.24

1.9

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

195

946

2.37

22.65

5.3

4.5

33.10

32.28

0.46

155

646

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

7.69

22.61

1.4

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

358

2212

2.05

22.55

7.2

3.8

23.88

7.12

mg/mmol

4.53

266

1363

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

122

4.65

22.49

9.5

2.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

139

4.40

22.44

1.7

1.6

—

(3026008) Bacteria identified in Urine by Culture

350

2152

2.05

22.28

4.4

2.9

—

(3026782) Osmolality of Urine

258

1419

2.16

22.06

7.0

2.7

479.44

543.87

mosm/kgh2o

7.21

231

1229

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

417

2745

2.00

21.77

5.5

3.5

950.27

50.37

ng/l

0.49

343

1886

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

162

737

2.47

21.62

4.4

3.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

32.08

21.59

1.9

4.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

204

3.70

21.45

1.6

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

9.21

21.28

4.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

9.21

21.28

4.1

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

8.90

20.74

4.2

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

16.28

20.70

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

229

1230

2.17

20.61

5.7

2.7

0.56

0.98

e6/l

3.49

173

690

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

17.43

20.60

1.0

—

(4035726) Immunohistochemistry procedure

149

667

2.49

20.52

2.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

123

4.43

20.45

2.0

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

151

4.04

20.13

2.8

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

142

628

2.51

20.05

11.7

7.7

1.36

mmol/l

0.01

134

616

(3028626) Oxygen [Partial pressure] in Capillary blood

204

3.59

19.98

19.8

4.0

9.02

8.51

kpa

1.29

199

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

7.58

19.60

4.2

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

7.58

19.60

4.2

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

112

4.48

19.20

2.1

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

7.71

19.18

1.9

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

7.71

19.18

1.9

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

278

1643

2.02

19.18

1.8

1.5

19.10

21.41

nmol/l

1.79

248

1390

(3015171) Extractable nuclear Ab [Units/volume] in Serum

278

3.15

19.10

1.4

1.2

0.24

1.58

u/ml

—

(3015736) pH of Urine

424

2896

1.91

19.02

7.3

3.2

5.50

5.87

0.66

237

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

164

794

2.31

18.86

8.8

8.2

4.99

5.14

kpa

1.57

155

767

(3003396) Base excess in Arterial blood by calculation

164

794

2.31

18.86

8.8

8.2

1.10

1.12

mmol/l

0.02

134

647

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

28.54

18.80

5.8

4.9

2.59

2.25

mg/l

—

(3013512) EKG study

335

2125

1.94

18.74

5.3

3.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

163

794

2.30

18.45

8.8

8.2

11.48

12.36

kpa

1.49

153

770

(3023419) Bacteria identified in Sputum by Culture

120

4.27

18.43

3.7

2.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

15.74

18.06

4.0

2.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

23.35

17.82

2.5

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

208

3.35

17.31

2.3

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

126

4.06

17.29

3.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

5.24

17.06

3.6

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

102

415

2.65

17.00

1.8

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

181

3.49

16.84

1.7

8438.04

14904.74

e6/l

0.72

137

(3051651) Icteric interference index of Serum or Plasma

5.94

16.74

4.4

3.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

203

3.32

16.61

1.4

1.2

19.11

11.36

u/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

7.45

16.59

1.0

1.1

1604.29

1654.52

miu/ml

0.06

(3035350) Ketones [Presence] in Urine by Test strip

488

3584

1.82

16.50

8.6

3.5

0.00

estimate

0.74

104

680

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

135

3.87

16.50

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

135

3.87

16.50

1.6

1.3

—

(3009261) Glucose [Presence] in Urine by Test strip

492

3626

1.82

16.41

8.6

3.5

0.00

0.01

estimate

0.80

618

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

6.45

16.36

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

273

1682

1.91

16.20

8.1

3.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

201

3.30

16.20

1.4

1.2

2.18

2.65

u/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

163

838

2.16

16.01

10.5

2.7

6.04

7.95

umol/l

1.73

148

736

(3037756) Immunofixation for Serum or Plasma

148

3.67

15.92

2.2

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

174

921

2.11

15.84

3.9

2.2

176.17

120.80

ug/g

0.68

146

739

(3021901) Oxygen saturation in Capillary blood

130

3.85

15.77

11.0

2.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

110

484

2.46

15.54

1.5

1.2

282.10

219.94

u/ml

0.26

102

447

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

4.94

15.54

1.8

1.2

—

(40768441) Liver Pathology biopsy report

5.15

15.35

2.5

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

483

3588

1.78

15.22

11.0

4.7

0.00

estimate

0.50

100

650

(3004616) Nuclear Ab [Presence] in Serum

4.32

14.72

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

193

3.21

14.57

2.2

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

199

3.16

14.48

4.7

3.9

—

1.86

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

4.35

14.46

2.3

1.6

47.90

61.26

1.08

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

5.65

14.37

2.8

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

201

3.13

14.24

4.8

4.0

34.40

44.60

mg/l

0.28

160

(3034860) Kappa light chains.free [Mass/volume] in Serum

201

3.13

14.24

4.9

4.0

56.93

85.14

mg/l

0.40

160

(3000570) Elastase.pancreatic [Mass/mass] in Stool

218

3.04

14.15

1.4

275.45

294.16

ug/g

0.28

126

(40768804) Tissue Pathology biopsy report

408

2934

1.74

13.99

2.8

2.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

152

3.43

13.87

2.6

1.8

4.55

5.06

mmol/24h

0.54

133

(40760888) Immunoglobulin light chains.free panel - Serum

153

3.41

13.74

5.0

4.3

—

(3051611) Lipemic interference index of Serum or Plasma

4.64

13.62

4.5

2.9

—

(3052851) Hemolysis interference index of Serum or Plasma

223

2.97

13.60

4.3

3.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

400

2882

1.72

13.46

2.3

1.9

98.20

96.88

pmol/l

0.21

233

1477

(1616796) Gas panel - Central venous blood

146

3.42

13.31

7.6

3.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

3.97

13.19

1.8

1.4

—

(3017732) Neutrophils [#/volume] in Blood

107

500

2.30

13.15

4.0

3.0

6.86

6.10

e9/l

0.14

416

(40767503) Oxygen content in Capillary blood by calculation

138

3.46

13.03

3.8

2.6

16.27

16.34

0.04

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

119

3.66

12.96

1.1

1.2

2.38

6.25

u/ml

1.09

(3003327) Ova and parasites identified in Stool by Light microscopy

230

2.88

12.87

1.5

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

236

2.85

12.84

2.3

2.5

8.42

10.48

g/l

3.30

214

(3022145) Colonoscopy Study observation

153

831

2.02

12.81

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

2.74

12.49

2.4

7.18

7.34

g/l

0.32

236

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

2.74

12.49

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

2.74

12.49

2.4

3.23

3.57

g/l

1.74

236

(40768443) Skin Pathology biopsy report

309

2.56

12.14

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

167

3.12

11.94

3.3

2.3

127.83

131.35

g/l

0.41

123

(3045424) Erythrocytes [Presence] in Urine

117

3.54

11.78

2.1

1.4

—

(3021788) Differential panel - Synovial fluid

137

3.33

11.78

2.2

1.6

—

(3025941) Bacteria identified in Stool by Culture

399

2.34

11.57

1.6

1.2

—

(3019060) Gas panel - Arterial blood

442

2.26

11.36

6.2

4.9

—

(3028433) Virus identified in Specimen by Culture

8.48

11.35

1.2

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

168

3.03

11.20

4.8

3.5

41.39

34.99

umol/l

0.40

153

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

243

2.67

11.09

2.5

2.99

2.92

g/l

0.20

222

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

338

2418

1.65

11.07

8.5

3.3

30.02

32.03

u/l

0.81

325

2302

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

220

2.75

11.05

3.1

2.7

0.32

0.95

g/l

1.15

199

(3028679) Herpes simplex virus Ab [Presence] in Serum

5.83

11.04

1.3

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

280

1909

1.69

11.03

10.6

3.7

0.00

0.01

estimate

1.08

636

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

190

1163

1.81

10.94

7.0

2.8

1.49

2.26

e6/l

0.86

134

630

(3017704) Immunofixation for Urine

5.66

10.73

1.3

1.4

—

(3021589) Normoblasts [#/volume] in Blood

431

3302

1.61

10.52

24.7

9.1

0.00

e9/l

0.20

379

2688

(3003181) Sodium [Moles/volume] in Urine

122

3.30

10.38

2.1

1.2

59.00

64.26

mmol/l

0.31

108

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.49

10.32

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

19.05

10.28

11.5

5.4

5.75

6.35

mmol/l

—

(3044927) Protein electrophoresis panel - Urine

3.97

10.19

1.3

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.41

10.10

1.2

—

(3012501) Base excess in Blood by calculation

136

3.11

9.93

8.2

3.8

2.15

2.56

mmol/l

0.40

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

203

2.72

9.93

2.4

2.6

37.95

37.96

g/l

0.00

182

(3009214) Lutropin [Units/volume] in Serum or Plasma

193

2.74

9.78

1.4

1.5

14.63

9.53

u/l

0.95

155

(21494890) Protein electrophoresis panel - 24 hour Urine

4.16

9.75

2.7

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

375

2.25

9.73

10.6

10.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

804

7339

2.28

9.62

46.4

13.6

19.66

23.00

mg/l

2.20

751

5759

(3010144) Erythrocytes [#/volume] in Synovial fluid

3.88

9.56

1.4

1.3

30865.87

135766.38

e6/l

0.60

(3019832) Treponema pallidum Ab [Presence] in Serum

100

518

2.05

9.43

2.1

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

114

3.25

9.41

1.1

1.2

2.53

4.45

u/ml

0.39

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.23

9.39

1.1

1.2

—

(3049717) Cytology report of Urine Cyto stain

264

2.45

9.38

2.7

2.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

4.43

9.38

3.2

2.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

3.10

8.94

1.4

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.99

8.92

1.5

1.1

—

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

202

1326

1.68

8.91

1.4

1.3

58.95

33.01

iu/ml

0.84

440

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

113

3.19

8.88

1.1

—

(3020891) Body temperature

265

2.40

8.84

9.9

4.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

8.33

8.60

2.8

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

16.48

8.57

3.1

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

216

1461

1.64

8.43

1.6

38674460.14

13516181.00

pmol/l

0.28

181

1206

(1761868) Lipid panel - Serum or Plasma

187

2700

0.61

8.20

3.4

2.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

118

682

1.84

8.06

5.2

2.5

40.21

34.85

u/l

0.44

107

591

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

10.15

8.05

1.4

1.1

—

(3042631) Mycobacterium sp identified in Specimen

3.27

8.00

3.1

2.6

—

(3024928) Oxygen saturation in Venous blood

172

2.64

7.95

12.1

2.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

6.67

7.91

1.1

1.2

1.06

1.02

ratio

—

(3008536) Aspergillus sp Ab [Presence] in Serum

8.56

7.83

4.8

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

432

2.02

7.73

9.6

7.3

24.47

24.56

mmol/l

0.08

414

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

104

588

1.87

7.60

2.8

2.4

10.95

7.59

ug/l

0.65

525

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

3.87

7.56

1.4

1.1

526.25

104.00

titre

—

(3008898) HLA-B27 [Presence]

272

2.25

7.49

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

141

881

1.72

7.37

11.8

6.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

2.98

7.34

1.5

1.1

—

(3011648) Oxygen content in Venous blood

3.66

7.34

14.2

2.0

11.89

11.07

0.44

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

3.32

7.15

2.0

2.4

—

(3000060) B lymphocytes [#/volume] in Blood

8.01

7.12

4.4

1.9

67.00

298.57

e6/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

468

1.93

7.06

1.3

—

49.18

—

(3045414) Leukocytes [Presence] in Urine

306

2.14

7.05

2.2

1.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

4.25

7.03

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

4.43

6.98

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.43

6.98

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

4.43

6.98

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

16.84

6.75

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.94

6.74

2.4

1.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

3.35

6.73

1.3

1.1

—

(40768797) Stomach Pathology biopsy report

159

1050

1.63

6.70

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

157

2.55

6.68

1.4

1.2

69.20

29.44

u/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

3.50

6.60

1.5

1.1

—

(3002256) Pathology report gross observation

144

931

1.66

6.60

1.4

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

185

1274

1.57

6.54

1.3

31.19

13.45

u/ml

1.09

486

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

3.56

6.47

1.1

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

570

4922

1.46

6.36

7.6

3.1

69.13

50.70

u/l

1.69

541

4604

(3009871) Measles virus Ab [Titer] in Serum

6.62

6.35

1.7

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

187

2.37

6.27

1.5

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

2.96

6.20

3.3

2.5

15.82

21.55

mg/l

0.47

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.34

6.18

2.1

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

6.34

6.18

2.0

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

116

2.73

6.14

1.1

1.0

—

(4200892) Spirometry reversibility

559

1.79

6.10

1.9

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.67

6.07

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

192

1355

1.54

6.05

6.1

3.8

357.84

394.85

ng/l

0.09

151

1035

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

670

0.38

6.04

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

436

1.87

5.92

2.5

3.0

4.22

4.60

pmol/l

2.22

383

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.45

5.89

3.2

2.9

46.15

38.83

0.90

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.75

5.66

1.2

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.67

5.39

1.3

1.2

38.43

38.20

g/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

467

0.31

5.38

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

7.94

5.35

1.7

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.83

5.34

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

6.74

5.26

3.3

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

+∞

5.21

2.2

0.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

164

2.31

5.21

1.6

1.2

3.76

3.84

mmol/l

0.13

153

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.98

5.17

1.3

1.9

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.41

5.15

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

7.41

5.15

2.4

2.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

128

2.47

5.09

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

13.44

5.08

2.0

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

2.81

5.07

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

8.41

5.07

1.8

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

8.41

5.07

1.8

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.41

5.07

1.2

85.30

94.25

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

8.41

5.07

1.8

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

142

2.38

4.97

1.8

1.6

—

(3014271) Vancomycin [Susceptibility]

4.39

4.95

2.4

2.3

—

(3047181) Lactate [Moles/volume] in Blood

218

2.07

4.75

7.1

6.3

1.32

1.31

mmol/l

0.05

193

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.25

4.57

2.4

1.4

—

(3019174) dRVVT (LA screen)

10.08

4.52

1.0

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.86

4.41

1.2

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

173

1277

1.44

4.26

3.2

3.1

2.47

2.45

mmol/l

1.24

154

1127

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.88

4.24

1.2

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

335

2765

1.34

4.21

10.0

3.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.94

4.13

1.9

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.90

4.08

1.5

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.05

4.01

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

112

2.36

3.95

3.0

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

109

745

1.53

3.93

2.9

4.3

10.21

25.72

ug/l

0.70

622

(3034891) Synovial lining cells/100 cells in Synovial fluid

4.11

3.91

3.1

1.3

2.75

2.00

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.73

3.80

1.3

1.0

0.93

1.13

u/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

8.81

3.78

1.0

1.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

8.81

3.78

9.4

4.4

—

(3019150) Specific gravity of Urine by Refractometry

205

1591

1.38

3.76

10.8

3.6

1.02

kg/l

0.56

224

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.05

3.69

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

219

1.92

3.65

1.5

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

2.68

3.58

1.8

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.65

3.50

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2.92

3.47

2.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

160

2.04

3.43

1.6

1.5

31.41

10.93

e6/l

0.49

122

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.79

3.43

3.2

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

210

1.90

3.40

1.3

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

552

1.56

3.40

2.6

2.2

12.50

12.99

nmol/l

0.27

501

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

7.04

3.37

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

220

1.86

3.28

1.6

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.37

3.23

1.4

2.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.20

3.20

1.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

131

2.10

3.15

1.3

1.2

64.28

15.05

u/l

0.86

113

(3017315) Amylase [Enzymatic activity/volume] in Urine

3.28

3.15

1.2

195.46

594.40

u/l

0.79

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

210

1680

1.33

3.12

1.4

1.3

3.10

1.76

u/ml

0.45

441

(42529406) Shigella sp [Presence] in Stool by Culture

224

1.82

3.12

1.6

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.20

3.06

7.1

3.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

514

4624

1.27

3.03

3.3

2.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

168

1.94

3.03

2.1

2.0

151.94

3888.83

u/l

1.24

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.38

3.00

3.3

3.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.32

3.00

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.32

3.00

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

4.32

3.00

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.32

3.00

1.1

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

10.05

2.98

1.0

—

(3045142) Bone marrow Pathology biopsy report

2.40

2.91

2.1

1.3

—

(21494755) Public health laboratory ask at order entry panel

702

0.59

2.89

1.2

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.61

2.88

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

794

7611

1.50

2.88

47.2

15.5

139.48

139.70

mmol/l

1.62

774

7427

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

5.42

2.87

1.1

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.70

2.87

1.0

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.36

2.81

1.6

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.36

2.81

1.6

1.7

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

795

7628

1.50

2.81

48.4

15.6

3.99

3.97

mmol/l

1.42

774

7433

(3032352) Blasts [#/volume] in Cerebral spinal fluid

8.37

2.75

2.4

5.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.03

2.73

1.4

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.03

2.73

1.0

—

(3034426) Prothrombin time (PT)

3.78

2.67

1.0

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.78

2.67

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

213

1.77

2.67

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.95

2.62

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.75

2.55

3.1

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.18

2.55

1.2

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

7.18

2.55

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.18

2.55

1.2

1.9

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

5.48

2.54

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.48

2.54

2.2

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

609

5649

1.26

2.52

4.9

3.9

15.00

14.74

pmol/l

1.57

564

5149

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.40

2.48

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

130

1.95

2.47

1.4

1.1

3.10

1.82

u/ml

0.18

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.69

2.46

3.1

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

117

1.99

2.42

1.2

1.1

2.28

7.52

u/ml

1.73

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

6.28

2.37

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

6.28

2.37

1.0

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

356

1.55

2.36

2.5

2.3

—

(3044941) Cell count panel - Synovial fluid

119

1.96

2.32

1.7

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

4.64

2.27

1.5

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

232

1955

1.25

2.25

8.0

3.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

5.58

2.21

1.6

2.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.58

2.21

2.8

1.4

54.80

38.00

umol/l

—

(3047189) Immunofixation for 24 hour Urine

2.88

2.21

2.9

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.88

2.21

2.9

1.3

—

(40761536) Microorganisms panel - Urine sediment

597

1.41

2.21

10.2

3.8

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.52

2.19

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

129

1.88

2.18

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

4.31

2.15

14.2

1.9

1.25

1.26

mmol/l

—

(4034850) Laboratory test

236

1.64

2.14

12.7

9.6

—

(3003694) ABO and Rh group [Type] in Blood

231

1957

1.25

2.13

1.6

1.4

—

(3000492) Spirometry study

100

760

1.36

2.10

2.0

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.09

2.08

9.8

2.2

34.24

32.82

0.84

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

117

914

1.32

2.05

2.2

1.8

1.52

1.47

0.36

807

(3001019) Free T4 and TSH panel - Serum or Plasma

376

0.55

2.03

1.5

1.7

—

(21494434) Karyotype in Bone marrow

2.24

2.01

1.6

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.10

2.01

8.0

4.7

—

(3044889) 12 lead EKG panel

481

5204

0.83

1.98

5.7

3.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

134

1.81

1.97

1.8

2.9

1.00

0.86

nmol/l

0.40

104

(3000012) Reticulocyte production index

2.04

1.96

10.2

2.4

—

(36660697) Celiac disease serology panel - Serum

611

1.38

1.95

1.2

—

(1002224) Polysomnography panel

320

0.52

1.95

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.58

1.94

1.0

1.2

—

(40758292) HTLV I+II Ab panel - Serum

4.56

1.94

1.2

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

731

7000

1.28

1.91

33.2

12.6

72.83

82.07

ml/min/173m2

15.87

666

5751

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

285

1.54

1.88

3.3

3.4

21.67

4558.01

u/ml

0.71

243

(3034988) Calcium [Moles/volume] in Capillary blood

3.55

1.84

15.5

1.7

1.22

1.21

mmol/l

—

(3052592) Norovirus Ag [Presence] in Stool

4.18

1.82

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.28

1.81

2.5

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.06

1.80

1.1

—

(4146454) Self-monitoring of blood glucose

1.99

1.75

2.9

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

239

2073

1.21

1.73

1.9

1.7

1.53

1.40

mmol/l

1.33

212

1750

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.68

1.72

2.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.93

1.72

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

3.86

1.71

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

111

1.82

1.70

1.3

1.1

1.55

1.69

u/ml

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.81

1.65

3.3

1.4

—

(40765096) Chromosome analysis panel by Banding

2.81

1.65

1.4

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.81

1.65

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.92

1.60

1.1

—

(3006462) Nitrate [Presence] in Urine

2.51

1.60

2.0

3.3

—

(3033799) Differential panel - Peritoneal fluid

2.71

1.58

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.71

1.58

1.3

1.2

—

(40768806) Pleura Pathology biopsy report

2.05

1.54

1.3

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

501

0.67

1.54

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.44

1.54

2.8

2.3

—

(3008295) Osmolality of Serum or Plasma

1.88

1.51

1.4

283.22

279.68

mosm/kgh2o

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.02

1.49

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.02

1.49

1.8

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.02

1.49

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.02

1.49

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.38

1.46

1.0

1.4

194.89

181.81

mmol/24h

—

(3048879) Bone marrow aspiration report

3.14

1.44

3.2

2.2

—

(3012441) Differential panel - Pleural fluid

2.05

1.44

1.6

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.44

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.44

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.98

1.44

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.74

1.43

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

157

1.61

1.42

1.9

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

807

7881

1.34

1.41

31.3

10.4

26.01

26.92

u/l

0.85

786

7626

(3051593) INR in Capillary blood by Coagulation assay

2.42

1.39

7.7

9.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

2.21

1.37

1.3

—

(40761511) CBC panel - Blood by Automated count

789

7687

1.29

1.36

38.5

12.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

120

1.68

1.35

1.5

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

147

0.47

1.33

1.0

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

207

0.53

1.32

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

186

1.52

1.28

4.4

2.3

45.73

74.97

ug/min

0.57

109

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

191

0.52

1.27

1.5

—

(3006653) Thiamine [Moles/volume] in Blood

2.30

1.27

1.1

1.3

157.13

160.63

nmol/l

—

(3022621) pH of Urine by Test strip

470

1.32

1.24

4.0

2.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

2.01

1.23

1.6

1.5

—

21.89

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.64

1.21

1.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

707

6828

1.19

1.21

8.7

5.6

39.96

39.66

mmol/mol

0.36

656

6353

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.32

1.19

1.3

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.51

1.15

37.4

5.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.01

1.12

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

112

1.62

1.09

1.2

1.0

0.95

1.87

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.20

1.08

1.7

1.2

11.49

8.96

ug/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

155

1768

0.85

1.06

3.5

4.1

22.82

20.75

0.92

815

(40768800) Prostate Pathology biopsy report

151

0.53

1.03

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

1.70

1.02

1.5

2.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1.90

1.01

5.6

2.0

0.60

2.52

u/field

—

(3011288) Drugs identified in Urine by Screen method

158

0.57

0.99

1.2

1.9

—

(40768793) Breast Pathology biopsy report

198

0.60

0.96

1.6

1.3

—

(3045788) Cell count panel - Pleural fluid

1.83

0.92

2.1

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

193

1.41

0.91

1.1

1.3

206.17

214.11

miu/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.64

0.91

1.1

1.0

16.57

6.03

u/ml

—

(3023410) Appearance of Cerebral spinal fluid

1.66

0.88

2.0

1.8

—

(3027008) Opiates [Presence] in Urine

240

0.66

0.87

1.3

1.5

—

(3028300) Cannabinoids [Presence] in Urine

240

0.66

0.87

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

239

0.66

0.85

1.3

1.5

—

(40768795) Lymph node Pathology biopsy report

1.68

0.85

1.3

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.94

0.84

1.7

2.9

291.67

197.32

u/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.94

0.84

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

238

0.67

0.84

1.3

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

121

1.50

0.83

1.5

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

114

1303

0.86

0.82

2.9

0.71

0.73

ug/l

0.19

843

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

130

1.47

0.81

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

696

6777

1.14

0.78

6.0

4.6

1.99

2.08

mu/l

0.20

649

6215

(3016879) Cocaine [Presence] in Urine

222

0.67

0.78

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

296

1.30

0.78

1.5

1.4

30.43

27.98

iu/l

0.11

254

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.53

0.72

1.1

1.0

8.36

3.85

u/ml

—

(3025130) Human papilloma virus identified in Specimen

1.59

0.72

1.8

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

118

1.45

0.69

1.2

—

(3024263) Appearance of Synovial fluid

1.67

0.68

1.9

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

385

1.23

0.67

1.6

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

181

1.34

0.63

2.6

1.8

2.48

4.61

iu/l

—

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.61

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.67

0.61

2.6

2.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

692

0.84

0.61

1.6

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

243

0.74

0.60

1.8

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

253

0.75

0.58

2.3

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

183

0.71

0.56

1.4

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

122

0.65

0.55

2.0

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

182

0.71

0.54

6.9

4.5

—

(3004451) EKG impression Narrative

1.54

0.53

1.5

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

232

1.26

0.53

1.7

1.8

36.34

39.76

nmol/l

0.45

225

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.62

0.52

1.2

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

181

1.28

0.48

2.5

2.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

815

8223

0.86

0.47

62.0

20.2

128.64

135.98

g/l

32.30

801

8114

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

117

0.68

0.46

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.40

0.45

2.4

1.4

86.29

72.80

umol/l

—

(3026361) Erythrocytes [#/volume] in Blood

815

8220

0.86

0.44

61.8

20.0

4.29

4.51

e12/l

22.79

797

7993

(3035941) MCH [Entitic mass]

815

8219

0.86

0.43

61.4

19.9

30.25

30.30

0.28

801

8113

(3024731) MCV [Entitic volume]

815

8218

0.87

0.43

61.5

20.0

92.07

90.93

8.63

801

8112

(3010813) Leukocytes [#/volume] in Blood

815

8218

0.87

0.43

61.8

20.0

7.35

6.62

e9/l

14.93

797

7992

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.66

0.42

1.3

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.52

0.41

1.0

1.1

82.46

185.91

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.41

0.0

1.0

—

(3007461) Platelets [#/volume] in Blood

815

8216

0.87

0.41

61.9

20.0

259.51

252.40

e9/l

1.99

799

8013

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

26.41

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

168

1.26

0.40

1.7

1.9

191.52

218.16

pmol/l

0.60

158

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.40

0.0

1.3

—

0.58

—

(3009542) Hematocrit [Volume Fraction] of Blood

815

8214

0.87

0.39

62.4

20.2

38.93

40.29

9.69

773

7719

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.39

0.0

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

234

1.20

0.37

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

1149

0.91

0.37

1.5

1.4

—

(3017569) Oxygen content in Arterial blood

1.35

0.37

2.2

3.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.35

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.68

0.33

1.3

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.67

0.33

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

106

0.75

0.29

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

106

0.75

0.29

1.4

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

740

7471

0.94

0.27

6.4

4.9

2.60

2.80

mmol/l

8.87

687

6921

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

114

1.23

0.25

1.1

1.0

7.62

2.15

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

283

1.14

0.25

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.19

0.24

1.2

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

713

7057

1.06

0.24

5.8

4.0

1.51

1.30

mmol/l

10.37

657

6492

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

1.21

0.24

1.1

—

(3000330) Specific gravity of Urine by Test strip

348

0.89

0.23

4.8

3.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

263

0.87

0.22

1.4

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

10.78

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.21

0.0

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

3.23

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.12

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

1.68

—

(3023511) Choriogonadotropin [Units/volume] in Urine

102

0.78

0.21

1.1

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

105

0.76

0.21

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

105

0.76

0.21

1.4

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.05

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.25

0.20

1.2

1.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.20

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

114

0.79

0.20

1.4

1.6

—

(44813793) Dust mix specific IgE antibody measurement

1.18

0.19

1.5

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

683

0.93

0.19

2.2

1.9

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

1.13

0.18

1.0

1.1

—

9.94

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.21

0.17

3.5

2.6

—

(3000034) Microalbumin [Mass/volume] in Urine

0.72

0.17

10.4

3.2

329.94

16.26

mg/l

—

(3035285) Chloride [Moles/volume] in Venous blood

1.20

0.16

3.5

2.6

106.09

105.04

mmol/l

0.61

(3041354) Potassium [Moles/volume] in Venous blood

1.20

0.16

3.5

2.6

4.15

4.01

mmol/l

0.35

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

188

1.12

0.15

1.0

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

325

0.92

0.13

1.4

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.14

0.10

1.2

1.5

5.12

6.03

ug/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

1.13

0.10

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.11

0.10

1.2

3.5

—

(3015183) Erythrocyte sedimentation rate

1.09

0.09

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

379

1.06

0.09

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

116

1.12

0.09

2.4

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

816

1.03

0.08

1.5

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

733

7302

1.02

0.07

6.1

4.4

1.46

1.48

mmol/l

0.34

682

6761

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.83

0.07

1.3

2.1

13.43

13.10

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

118

1.10

0.07

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

222

2195

1.02

0.05

4.0

4.7

1.82

2.29

ug/l

1.34

192

1984

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

613

1.03

0.05

2.0

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

719

7212

0.98

0.05

6.9

4.5

5.86

5.94

mmol/l

0.78

670

6607

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.09

0.03

1.6

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

735

7337

1.01

0.02

6.1

4.5

4.59

4.72

mmol/l

2.94

685

6825

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1.02

0.00

1.6

1.2

—

0.54

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

494

0.99

0.00

1.2

54.08

136.81

iu/ml

2.18

210

(3051387) C reactive protein [Mass/volume] in Capillary blood

158

1.01

0.00

4.7

3.5

21.11

22.21

mg/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

130

1305

1.00

0.00

1.6

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.01

0.00

1.6

1.2

80.52

0.59

nmol/l

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.0

1.9

—

1.79

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.0

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.0

4.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.88

-0.00

1.2

8.68

6.29

mmol/l

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

6.6

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

77.20

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

4.8

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

30.00

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

-0.00

0.0

1.4

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.0

—

7.78

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.90

-0.00

1.8

1.3

—

nmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint DRUGADVERS_CATAR and mortality.

Females

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.266 [2.86, 3.73]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.061

During the follow-up period (1.1.1998 — 31.12.2019), 634 out of 2151 females with DRUGADVERS_CATAR died.

Males

Parameter	HR [95% CI]	p-value
DRUGADVERS_CATAR	3.542 [3.09, 4.06]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 578 out of 1606 males with DRUGADVERS_CATAR died.

Mortality risk

Mortality risk for people of age

years, who have DRUGADVERS_CATAR.

N-year risk	Females	Males
1	0.22%	0.562%
5	2.003%	3.4%
10	4.599%	9.293%
15	8.461%	17.053%
20	13.692%	27.482%

Relationships between endpoints

↥

Index endpoint: DRUGADVERS_CATAR – Drug-induced cataract

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Drug-induced cataract

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints